(19)
(11) EP 3 701 938 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.02.2024 Bulletin 2024/08

(45) Mention of the grant of the patent:
15.11.2023 Bulletin 2023/46

(21) Application number: 19160293.7

(22) Date of filing: 01.03.2019
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 47/10(2017.01)
A61K 47/22(2006.01)
A61K 47/36(2006.01)
A61K 31/46(2006.01)
 A61K 47/02(2006.01)
A61K 47/20(2006.01)
A61K 47/26(2006.01)
A61K 47/40(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0048; A61K 31/46; A61K 47/02; A61K 47/10; A61K 47/20; A61K 47/22; A61K 47/26; A61K 47/36; A61K 47/40

(54)

OPHTHALMIC FORMULATIONS BASED ON ATROPINE

OPHTHALMISCHE FORMULIERUNGEN AUF BASIS VON ATROPIN

FORMULATIONS OPHTALMIQUES À BASE D'ATROPINE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Validation States:
MA MD TN

(43) Date of publication of application:
02.09.2020 Bulletin 2020/36

(73) Proprietor: Medivis S.R.L.
95030 Tremestieri Etneo (CT) (IT)

(72) Inventors:
  • ALEO, Danilo
    I-95030 Tremestieri Etneo, Catania (IT)
  • MELILLI, Barbara
    I-95030 Tremestieri Etneo, Catania (IT)
  • SAITA, Maria Grazia
    I-95030 Tremestieri Etneo, Catania (IT)
  • SPITALERI, Fabiola
    I-95030 Tremestieri Etneo, Catania (IT)
  • MANGIAFICO, Sergio
    I-95030 Tremestieri Etneo, Catania (IT)
  • CRO, Melina
    I-95030 Tremestieri Etneo, Catania (IT)

(74) Representative: Croce, Valeria 
Jacobacci & Partners S.p.A. Via Senato, 8
20121 Milano
20121 Milano (IT)


(56) References cited: : 
CN-A- 108 338 969
 US-A1- 2009 312 724
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).